
American Thoracic Society - ATS
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Thoracic Society - ATS — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
American Thoracic Society (ATS) International Conference — Deep Research Buyer & Attendee Analysis
Source-verified event basics (from the official ATS Conference site)
- Event: ATS (American Thoracic Society) International Conference / ATS 2026 (referenced on the official site)
- Official website reference: http://conference.thoracic.org/
- Dates: (Not reliably stated in the provided official site text excerpt)
- Venue: (Not reliably stated in the provided official site text excerpt)
- City: (Not reliably stated in the provided official site text excerpt)
- Country: (Not reliably stated in the provided official site text excerpt)
Event overview (what ATS 2026 represents)
The American Thoracic Society International Conference is positioned on the official ATS conference site as a high-impact scientific and educational meeting centered on respiratory health. The page also highlights that ATS 2026 includes an accredited Continuing Medical Education (CME) offering through the ACCME framework, and it promotes ATS NOW, an on-demand learning platform that includes personalized content derived from the conference programming.
From a buyer-fit perspective, this matters because ATS-style conferences typically attract a dense mix of: (1) clinical leaders and researchers, (2) medical education decision makers, (3) translational science and innovation stakeholders, and (4) industry medical/clinical teams who need to engage with credible respiratory medicine audiences.
1) Who attends (BUYERS / ATTENDEES)
This event is not just “general healthcare.” Based on the conference structure shown in the official site navigation (e.g., CME, innovation-themed programming, and multiple clinical/academic tracks), the attendee base is best understood as a blend of:
A) Primary attendee groups (clinical + academic)
- Pulmonologists / respiratory physicians and clinical specialists aligned to lung disease, respiratory critical care, and related sub-specialties
- Researchers (pulmonary/respiratory research, translational science, inhalation research, and clinical trials investigators)
- Academic faculty including department leadership, program chairs, and laboratory/center leaders
- Nursing and allied health professionals involved in respiratory care research and practice (the speaker list includes PhD/RN roles)
- Medical educators and education administrators who influence curriculum and professional learning
B) Buyer categories that frequently monetize engagement at ATS-type meetings
- Medical Education & Scientific Communications leaders (medical education strategy, content alignment, and accredited learning needs)
- Clinical Affairs / Medical Affairs decision makers (evidence generation, field medical strategy, and KOL engagement)
- Clinical Research & Trial Operations leadership (site engagement, investigator networks, trial awareness)
- Respiratory innovation stakeholders (often overlapping with industry sponsored innovation programming)
- Healthcare organizations’ research leadership (centers, divisions, and specialty hospitals)
C) Why “buyers” exist here (not only exhibitors)
The official page states the conference includes ACCME-accredited CME and provides ATS NOW access for conference registration. That combination usually correlates with higher concentration of: medical education stakeholders, accredited content buyers/influencers, clinical evidence leaders, and industry medical/clinical teams.
2) Where the show is happening + attendee geographic origin
From the official excerpt provided, the exact venue, city, and country for ATS 2026 are not stated. Because the dates and location are not reliably present in the supplied text, we are leaving them blank rather than guessing.
For geographic origin, the official excerpt only references “ATS International Conference,” which implies international reach, but it does not enumerate attendee origin by region or provide statistics about country representation. Therefore, we can’t claim a specific country/city origin distribution based strictly on the provided text.
What we can still say reliably (based on the official page)
- International brand + international audience signaling: The conference is explicitly named “ATS International Conference,” and speakers listed include international institutions (e.g., Universidad Nacional Autónoma de México appears on the speaker list), indicating cross-border participation.
- Primary relevance likely North America + global professional participation: However, “likely” is not a substitute for official attendee-origin statistics; we will treat this as directional only.
3) Audience reach (Local / National / Global)
The official title includes “International Conference,” and the site’s programming includes internationally relevant research and education materials (including ATS NOW, which extends learning beyond the conference dates). This combination typically supports global-level professional reach rather than local-only impact.
Because the official excerpt does not provide explicit metrics (e.g., total registered attendee count, country breakdown, or “reach” claims), the safest output is:
- Reach classification: Global professional reach (international designation + international speaker/institution evidence)
- Local vs national: Not quantified in the provided excerpt
4) Sample buyer company names (BUYERS ONLY) + websites
Important note: The official excerpt provided lists people and academic/medical institutions in the speakers section, but it does not list exhibitor/sponsor companies or a buyer list. For “buyer companies,” we should target organizations that typically buy engagement at respiratory medicine conferences (medical affairs, clinical research services, respiratory device and diagnostics manufacturers, and healthcare innovation support services).
Below is a starter buyer list of likely ATS-attractive buyers. We will refine it after we review your product requirements (see section 8).
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Johnson & Johnson (Janssen) | https://www.janssen.com | Director, Medical Affairs / Therapeutic Area Medical Director | Respiratory disease brands typically require KOL engagement and evidence education alignment through major society meetings. |
| 2 | AstraZeneca | https://www.astrazeneca.com | Global Medical Director (Respiratory) / Head of Respiratory Medical Affairs | Major respiratory franchise fit; conference engagement helps support clinical education and medical strategy. |
| 3 | Genentech (Roche) | https://www.gene.com | Medical Director, Clinical Evidence & Publications / Respiratory Medical Affairs Lead | Evidence-focused medical teams often participate in high-quality respiratory science conferences to refine clinical narratives. |
| 4 | Merck & Co., Inc. (Merck MSD) | https://www.merck.com | Associate Director, Medical Affairs (Respiratory) / Clinical Research Medical Affairs | Respiratory programs benefit from conference-based knowledge exchange and investigator/physician engagement. |
| 5 | GSK (GlaxoSmithKline) | https://www.gsk.com | Therapeutic Area Director, Medical Affairs (Respiratory) | Respiratory medicine teams commonly use ATS-type venues to support education, field medical alignment, and KOL reach. |
| 6 | Sanofi | https://www.sanofi.com | Medical Director / Head of Medical Affairs (Respiratory) | Strong alignment for respiratory indications; major society meetings support clinical strategy and collaboration. |
| 7 | Roche Diagnostics | https://diagnostics.roche.com | Director, Medical Affairs / Clinical Strategy (Diagnostics) | Diagnostics and biomarker stakeholders fit well where respiratory research and innovation are emphasized. |
| 8 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, Strategic Partnerships / Global Marketing (Life Sciences Research) | Respiratory research conferences attract lab instrumentation and research workflow buyers supporting academic/clinical studies. |
| 9 | IQVIA | https://www.iqvia.com | Director, Healthcare Market Access / Executive Director, Clinical Research Analytics | Evidence generation, market intelligence, and clinical research analytics frequently partner with respiratory research ecosystems. |
| 10 | CRO (Parexel) | https://www.parexel.com | VP, Clinical Operations / Director, Clinical Research (Respiratory) | Clinical trials and respiratory evidence development are common needs for CRO leadership targeting investigator networks. |
| 11 | CRO (ICON plc) | https://www.iconplc.com | Director, Clinical Research / Therapeutic Area Head (Respiratory) | Therapeutic area leadership benefits from major conferences where respiratory investigators and clinical leaders gather. |
| 12 | Medtronic | https://www.medtronic.com | Director, Clinical Affairs (Respiratory / Sleep) / Value & Evidence Lead | Where devices intersect with respiratory care and clinical outcomes, ATS-style engagement supports clinical evidence and education. |
| 13 | ResMed | https://www.resmed.com | Director, Medical Affairs / Clinical Evidence Lead | Respiratory-related therapies (e.g., sleep and pulmonary care adjacency) align to respiratory medicine audiences. |
| 14 | Philips (Healthcare) | https://www.philips.com | Head of Clinical Evidence / Director, Strategic Partnerships (Healthcare Informatics) | Healthcare technology and clinical evidence stakeholders often attend to align solutions with pulmonology and respiratory research needs. |
| 15 | Vyaire Medical | https://www.vyaire.com | Director, Medical Affairs / Clinical Education Program Lead | Airway and respiratory support markets typically seek conference access for education, KOL, and medical strategy collaboration. |
| 16 | Amgen | https://www.amgen.com | Associate Director, Medical Affairs (Immunology/Respiratory) / Evidence Lead | Respiratory indications involving immune pathways can benefit from society-driven educational exchange. |
| 17 | Boston Scientific (Respiratory-adjacent solutions) | https://www.bostonscientific.com | Director, Clinical Affairs / Medical Education & Evidence Lead | Some respiratory-related interventions overlap with broader clinical device ecosystems that attend major clinical conferences. |
| 18 | AbbVie | https://www.abbvie.com | Medical Director, Clinical Evidence / Respiratory Medical Affairs | Respiratory disease programs often leverage major medical society meetings for KOL engagement and education strategy. |
Best “starter” priorities to pursue first (based on buyer-likelihood)
- AstraZeneca, AstraZeneca Medical Affairs leaders
- GSK, Respiratory Medical Affairs
- AstraZeneca / Medical Director, Respiratory Medical Affairs (paired targeting)
- ResMed, Director, Medical Affairs / Clinical Evidence
- Roche Diagnostics, Director, Medical Affairs / Clinical Strategy (Diagnostics)
5) Job profiles, industries & event type
Event type (best-fit classification)
- Medical society conference
- Continuing Medical Education (CME) / accredited education (explicitly stated: ACCME-accredited CME)
- Respiratory science + innovation + clinical research ecosystem meeting
Best job profiles to target
- Medical Affairs leadership (Director / Head / Global Medical Director, Respiratory / Pulmonology / Critical Care)
- Clinical Research leadership (Clinical Trials Director, Therapeutic Area Clinical Research Lead)
- Scientific Communications & Medical Education (Medical Education Director, Scientific Communications Lead, Publications & Evidence Strategy)
- Clinical Evidence & Outcomes (Evidence Generation Lead, HEOR/Evidence Director if applicable)
- Strategic Partnerships (Partnership Director for innovation collaborations and academic relationships)
- Diagnostics / Device clinical stakeholders (Clinical Strategy, Regulatory/Clinical Liaison roles where relevant)
Industries to use (aligned to the provided industry filter list)
We’ll map ATS conference buyer fit to industries from your specified list. These are the most relevant categories for the buyer companies likely to engage here:
- Pharmaceuticals
- Medical Devices
- Hospital & Health Care
- Biotechnology
- Research
- Health, Wellness & Fitness (only where the buyer is broader care delivery connected to respiratory health)
- Professional Training & Coaching (only for medical education / accredited content providers)
- Marketing & Advertising (for medical/brand strategy communications teams)
- Information Technology & Services (only if the buyer is digital health, clinical informatics, respiratory monitoring platforms)
6) Estimated attendance (expected total footfall)
The provided official excerpt does not include an attendance estimate (no total footfall number, no exhibit-only attendance figure, and no registration counts). Therefore, we cannot responsibly state an expected total attendance based strictly on this supplied text.
Attendance estimate: (Not stated in the provided official excerpt)
7) Key focus areas & buyer engagement
A) Education and accredited learning are central
The official page explicitly states that ATS is accredited by ACCME to provide continuing medical education for physicians. This usually creates high demand for:
- evidence-aligned education materials
- medical education initiatives and curricula support
- conference content that can be distributed/extended (the page mentions ATS NOW on-demand access through Dec. 31, 2026)
B) Respiratory innovation and applied science themes
The conference navigation includes program elements such as “Respiratory Innovation Summit,” indicating that beyond core clinical sessions, the meeting also targets innovation translation and applied research ecosystems.
C) Innovation + industry engagement pathways
The conference site navigation references industry engagement mechanisms such as:
- Industry Supported Evening Symposia
- Industry Theaters
- Innovation Hubs
- Information for Medical Education and Communication Companies (MECC)
For buyers, this translates into multiple engagement formats—not only exhibitor hall access—meaning buyer audiences tend to include medical education and clinical communications leaders who can justify program sponsorships and content placements.
D) Engagement angle that typically converts for ATS-like events
- Align to respiratory evidence & accredited education outcomes (CME-aligned messaging and physician-focused learning)
- Target therapeutic/respiratory medical decision makers (medical affairs, clinical evidence, research leadership)
- Emphasize innovation translation (where innovation summit themes exist)
- Use content longevity (ATS NOW is described as on-demand, with access through Dec. 31, 2026)
8) Client-product fit note (required): we need your client website to identify best buyer segments
To determine the best buyers for this conference based on your exact client needs, we must review the client’s product and positioning. The ATS buyer fit changes materially depending on whether the client sells (for example) pharmaceuticals, devices, diagnostics, research tools, medical education services, digital health, or clinical trial support.
Please provide (so we can tailor the best buyer list)
- Client product / offer name
- Client website URL
- What the client wants to achieve (examples: targeted conference outreach, sponsorship lead gen, meeting discovery, KOL identification, clinician education leads)
- Preferred geography (if any)
- Any compliance constraints (especially if the product involves physician prescribing or clinical claims)
While we wait, here’s how we will map typical ATS client types to buyer titles
- If your client sells respiratory therapeutics: target Medical Affairs (Director/Head/Global Medical Director) and Clinical Evidence/Evidence Generation leadership.
- If your client sells respiratory diagnostics/device technology: target Director of Clinical Strategy, Medical Affairs, Clinical Evidence, and Strategic Partnerships.
- If your client sells clinical research services (CRO/analytics): target Therapeutic Area Clinical Research leaders and Clinical Operations VPs/Directors.
- If your client sells medical education or communications solutions: target Medical Education leads and those referenced by “MECC” style roles (where applicable to the sponsor/industry program model).
- If your client sells digital health / informatics for respiratory monitoring: target Evidence/HEOR-informed clinical leadership and partnership directors in healthcare technology.
What we will deliver once you share your client website
- A prioritized buyer list (with company names + websites)
- Role-specific targeting titles for your exact product category
- Industry mapping using your provided industry filter list
- Buyer-fit scoring for ATS 2026 attendee engagement potential
9) Final recommendation: is ATS Conference a good fit for attendee and buyer research?
Yes—ATS International Conference is a strong fit for deep buyer research in respiratory medicine because the official page emphasizes accredited CME and multiple industry engagement pathways (symposia, theaters, innovation hubs, and industry program mechanics).
The buyer density is typically strongest in medical affairs, clinical evidence, accredited medical education stakeholders, and innovation/partnership roles aligned to respiratory health.
Quality-fit summary (based on what’s verifiable from the official excerpt)
- Strategic relevance to healthcare buyers: High (CME + respiratory-focused conference branding)
- International reach signaling: High (international conference naming + international institutions in speaker list)
- Data completeness from provided excerpt: Medium (no explicit venue/date/attendance numbers included in the provided text)
- Actionability right now: Medium (we can produce buyer-title strategy; we need your client website for “best buyer” precision)
Quick checklist for next step
- Send the client website URL and a 2–3 sentence product description.
- Confirm your preferred target geography (e.g., US only vs global).
- Tell us whether your priority is: pharma/biotech buyer leads, device/diagnostics buyers, clinical research buyers, or medical education/communications buyers.
Once we have the client website, we will refine the buyer list for ATS into a “best buyer fit” set tailored to your specific requirements (company + titles + matching industry categories from your filter list).
Data sheet
Location: New Orleans, Louisiana, United States
Event Status: Upcoming
Research Date: 30 June 2026
| Event Name | American Thoracic Society - ATS |
| Event Date | 16 May 2027 – 19 May 2027 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the supplied official source excerpt |
| City | New Orleans |
| State / Region | LA |
| Country | United States |
| Organizer | American Thoracic Society |
| Official Event Website | conference.thoracic.org |
| Event Type | Annual medical society conference, scientific congress, education, exhibit and sponsorship event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | Global scientific and clinical audience with strong North American concentration |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium. Official conference pages confirm the event format and participant ecosystem, but no current-year attendance figure was provided in the supplied source text. |
| Main Purpose of Event | To convene respiratory medicine, pulmonary care, critical care, sleep medicine, and thoracic research communities for scientific education, professional networking, CME, exhibits, and industry engagement. |
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical leaders | Hospitals, health systems, pulmonary practices, academic medical centers | Define clinical pathways, evaluate therapies, influence formulary and protocol adoption | High value for pharma, devices, diagnostics, and digital health |
| Pulmonologists / critical care physicians | Specialty clinics, hospitals, research institutions | Clinical decision makers and key influencers | Core audience for respiratory therapies, procedures, and monitoring solutions |
| Respiratory therapists / care teams | Hospitals, rehab centers, home health providers | Influence equipment selection and workflow adoption | Relevant for ventilators, nebulizers, oxygen solutions, monitoring tools |
| Researchers / principal investigators | Universities, research institutes, teaching hospitals | Study design, trial collaboration, research procurement | Important for clinical trials, lab tools, data platforms, and grants support |
| Hospital administrators / operations leaders | Hospitals, health systems, outpatient networks | Budget ownership, purchasing oversight, service-line planning | Strong fit for capital equipment, software, facilities, and service vendors |
| Procurement / sourcing teams | Health systems, medical universities, public hospitals | Supplier evaluation, contract negotiation, vendor onboarding | Key for enterprise sales, distribution, and GPO engagement |
| Industry sponsors / exhibitors | Pharma, biotech, medtech, diagnostics, digital health | Commercial partnership, exhibit spend, brand activation | Direct sponsor and exhibitor-to-supplier networking potential |
| Association leaders / educators | Professional societies, accreditation bodies, training groups | Education partnerships, program development, advocacy influence | Relevant for learning platforms, publishing, and sponsorships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: New Orleans | Local hospitals, universities, medical staff, regional suppliers | Medium | Convenient for Gulf South participation and local healthcare networks |
| Host state / region: Louisiana and Gulf South | Regional health systems, academic centers, public health stakeholders | Medium to High | Strong regional pull for clinicians, researchers, and healthcare buyers |
| Nearby business hubs | Houston, Dallas, Atlanta, Birmingham, Orlando, Memphis | High | Major healthcare and medical research markets within practical travel range |
| National reach | US physicians, hospitals, universities, vendors, and sponsors | High | ATS has a strong national audience through its society structure and education programming |
| International reach | Global respiratory medicine and thoracic research community | High | The ATS brand and scientific program support international participation and partnership interest |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | ATS serves an international respiratory and thoracic medicine audience with scientific, clinical, and commercial participation. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Harvard T.H. Chan School of Public Health | Academic / research buyer | Speaker organization in ATS 2026; strong respiratory research relevance | hsph.harvard.edu | Chair, Professor, Research Director, Clinical Research Lead | Confirmed Speaker Organization |
| Medical University of South Carolina | Academic medical center | Speaker organization in ATS 2026; clinical and training buyer profile | musc.edu | Department Chair, Division Chief, Director of Education, Procurement Lead | Confirmed Speaker Organization |
| Louisiana State University School of Veterinary Medicine | Research institution | Speaker organization in ATS 2026; inhalation and respiratory research relevance | lsu.edu | Professor, Lab Director, Research Administrator, Grant Manager | Confirmed Speaker Organization |
| National Jewish Health | Specialty hospital / research center | Major respiratory care and research organization; ATS-aligned buying center | nationaljewish.org | CMO, Clinical Director, Research Director, Procurement Manager | Confirmed Speaker Organization |
| University of Rochester Medical Center | Academic medical center | Speaker organization in ATS 2026; pulmonary and oncology cross-over care | urmc.rochester.edu | Division Chief, Department Chair, Research Administrator, Sourcing Lead | Confirmed Speaker Organization |
| University of Cincinnati | University / medical education | Speaker organization in ATS 2026; good target for research, training, and event sponsorship | uc.edu | Program Director, Department Chair, Research Director, Purchasing Manager | Confirmed Speaker Organization |
| Georgetown Law | Policy / legal thought leadership | Speaker organization in ATS 2026; relevant for health policy, regulation, and advocacy conversations | law.georgetown.edu | Professor, Policy Director, Counsel, Government Relations Lead | Confirmed Speaker Organization |
| Callen-Lorde Community Health Center | Community health provider | Speaker organization in ATS 2026; care delivery and public health relevance | callen-lorde.org | Medical Director, Operations Director, Procurement Lead, Program Manager | Confirmed Speaker Organization |
| American Thoracic Society | Organizer / association buyer | Organizer and commercial sponsor marketplace operator | thoracic.org | Sponsorship Manager, Exhibits Manager, Meeting Planner, Partnership Director | Confirmed Government / Procurement Organization |
| ATS Conference Exhibitor Directory | Exhibitor ecosystem | Useful for identifying supplier categories and commercial presence | conference.thoracic.org | Brand Manager, Exhibit Manager, Regional Sales Director, Market Access Lead | Confirmed Sponsor / Exhibitor |
| ATS Conference Speakers | Clinical / academic influencer group | Speaker organizations indicate the event’s clinical decision-maker mix | conference.thoracic.org | Professor, Associate Professor, Medical Director, Division Chief | Confirmed Speaker Organization |
| ATS scholarships and awards community | Early-career / education buyer group | Shows strong education and training participation; relevant for learning solutions | thoracic.org | Program Coordinator, Faculty Lead, Training Director, Education Manager | Prior-Year Participation Evidence |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer | Executive / Clinical | C-level | Approves clinical strategy and high-value partnerships. |
| 2 | Director of Pulmonary / Respiratory Care | Clinical Operations | Director | Owns therapeutic workflow and equipment evaluation. |
| 3 | Chief Procurement Officer | Procurement | C-level | Controls sourcing strategy and vendor selection. |
| 4 | Director of Supply Chain | Supply Chain | Director | Influences purchasing, logistics, and contracted services. |
| 5 | Clinical Research Director | Research | Director | Drives trial participation, data platforms, and research procurement. |
| 6 | Procurement Manager | Procurement | Manager | Handles RFPs, supplier comparisons, and contracts. |
| 7 | Category Manager | Procurement / Supply Chain | Manager | Evaluates specialized medical and research categories. |
| 8 | Operations Director | Operations | Director | Owns workflow efficiency, service delivery, and budget alignment. |
| 9 | Medical Affairs Director | Medical Affairs | Director | Influences KOL engagement, education, and evidence generation. |
| 10 | Partnerships Director | Business Development | Director | Leads sponsor, alliance, and commercialization conversations. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core ATS audience and buying center | Hospital leaders, service-line buyers, clinical decision makers |
| 2 | Pharmaceuticals | Therapeutics, trials, and medical affairs presence | Medical affairs, brand, market access, and partnerships |
| 3 | Medical Devices | Respiratory devices and patient monitoring solutions | Product managers, commercial leaders, clinical specialists |
| 4 | Biotechnology | Research and innovation ecosystem | R&D collaboration, clinical study outreach |
| 5 | Research | Scientific and translational research buyers | University labs, research sponsors, grant-funded teams |
| 6 | Biotechnology | Pipeline and evidence-generation activities | Clinical development, scientific exchange |
| 7 | Information Technology & Services | Digital health, analytics, and research platforms | Health IT, workflow software, data integration |
| 8 | Education Management | CME, training, and professional education | Learning platforms, accreditation support, education services |
| 9 | Government Administration | Public health and policy stakeholders may attend | Public sector health programs, policy outreach |
| 10 | Marketing & Advertising | Commercial sponsors and exhibitor demand | Brand activation, congress marketing, exhibit support |
| 11 | Market Research | Evidence, advisory boards, KOL insights | Research services and healthcare insights buyers |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed by the organizer | Confirmed non-disclosure | Official ATS conference pages in supplied source excerpt | No current-year total attendance figure was provided |
| Exhibitor count | Not publicly confirmed in supplied excerpt | Unavailable | Exhibitor directory / floorplan referenced on official site | Directory exists, but count not included in supplied text |
| Buyer count | Not publicly confirmed | Unavailable | Derived from expected attendee mix | Most attendees are clinical, research, and academic buyers |
| Speaker count | Not publicly confirmed in supplied excerpt | Unavailable | ATS 2026 speaker examples listed on official page | Only sample speakers were visible in the excerpt |
| Sponsor count | Not publicly confirmed in supplied excerpt | Unavailable | Official exhibit/sponsor menu | Commercial participation is clearly supported, but counts are not shown |
| Historical attendance | Use official conference history / past program pages for prior-year validation | Historical evidence | ATS conference history and past program itineraries | Helpful for trend analysis when current-year counts are not published |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Respiratory therapeutics | Clinical outcomes, treatment efficacy, patient adherence | Target KOLs, formulary influencers, and specialty prescribers | Pharmaceutical products, patient support programs, evidence services |
| Diagnostics and monitoring | Earlier diagnosis, better tracking, less manual work | Demonstrate workflow savings and clinical value | PFT tools, imaging, connected monitoring, software |
| Research and clinical trials | Trial design, recruitment, data quality, publication support | Engage investigators and research administrators | CRO services, EDC, patient recruitment, analytics |
| Hospital operations | Efficiency, cost control, service quality | Identify budget holders and operational buyers | Workflow tools, managed services, procurement support |
| Education / CME | Accredited learning and professional development | Partner with societies, universities, and training teams | Learning platforms, content development, accreditation support |
| Commercial sponsorship | Brand visibility, thought leadership, lead generation | Industry theaters, hubs, symposia, booth programs | Event sponsorship, exhibit packages, branded content |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Attendees are concentrated in clinical, academic, research, and healthcare purchasing roles. |
| Decision-maker availability | High | Many senior clinicians, researchers, directors, and sponsor stakeholders are part of the audience. |
| Data collection potential | High | Exhibitor directories, speaker lists, program tracks, and sponsorship pages support lead profiling. |
| Apollo targeting potential | Very High | Strong fit for healthcare, pharma, medtech, research, and education targeting in Apollo. |
| Geographic targeting potential | Medium to High | Useful for US and global outreach, especially hospitals, universities, and specialty providers. |
| Best outreach approach | High-value, clinically relevant, evidence-led | Use scientific value propositions, clinical outcomes, and operational ROI. |
| Overall lead quality | Very High | ATS is a strong event for specialized B2B healthcare lead generation and attendee profiling. |
| Best use case | Conference attendee list building and healthcare account targeting | Ideal for exhibitors, sponsors, medtech/pharma, clinical software, and research services. |
| Limitations / risks | No current-year attendance list or exact footfall in the supplied excerpt | Prospecting should rely on official directories, speaker lists, and prior-year evidence where necessary. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Medical Devices; Biotechnology; Research; Information Technology & Services; Education Management | Focus on the most relevant buyer ecosystems for ATS. |
| Departments | Clinical, Medical Affairs, Procurement, Supply Chain, Operations, Research, Education, Business Development | Reach both clinical influencers and commercial buyers. |
| Seniority | Manager, Director, VP, CXO, Owner, Head | Prioritize decision-makers and budget holders. |
| Job titles | CMO, Medical Director, Division Chief, Director of Pulmonary, Procurement Manager, Sourcing Director, Clinical Research Director, Partnerships Director, Product Manager | High-intent titles aligned with clinical and purchasing influence. |
| Geography | United States; Canada; Europe; Global metro healthcare hubs | Matches ATS’s international audience and US-hosted attendance. |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001+ | Covers hospitals, universities, health systems, and enterprise vendors. |
| Keywords | pulmonary, respiratory, thoracic, critical care, sleep medicine, oxygen, ventilator, inhalation, clinical research, CME, medical affairs | Narrow search to ATS-relevant accounts and personas. |
| Company type | Hospital system, academic medical center, university, pharma, medtech, research institute, association | Filters for organizations most likely to buy or influence buying. |
| Technologies | EHR, clinical workflow, digital health, analytics, CRM, webinar, learning management systems | Useful for software and services vendors targeting ATS buyers. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| American Thoracic Society Conference Website | Official organizer website | Conference branding, exhibit/sponsor structure, agenda ecosystem, prior conference activity, speaker examples | High |
| American Thoracic Society Main Site | Official society website | Organizer identity, society mission, and broader audience context | High |
| ATS Conference Pages | Official event pages | Conference history, education tracks, exhibit/sponsor sections, attendee resources | High |
| ATS Press / News | Official event news | Conference announcements, event positioning, and participant ecosystem updates | High |
| Future Conferences Page | Official future event reference | Upcoming event listing and scheduling context | High |
| ATS Exhibit / Sponsor Section | Official commercial participation page | Exhibit, sponsorship, industry program, and directory structure | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Thoracic Society - ATS — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.